Association of Cardiac Biomarkers With the Kansas City Cardiomyopathy Questionnaire in Patients With Chronic Kidney Disease Without Heart Failure

Background The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a measure of heart failure (HF) health status. Worse KCCQ scores are common in patients with chronic kidney disease (CKD), even without diagnosed heart failure (HF). Elevations in the cardiac biomarkers GDF‐15 (growth differentiation...

Full description

Bibliographic Details
Main Authors: Sri Lekha Tummalapalli, Leila R. Zelnick, Amanda H. Andersen, Robert H. Christenson, Christopher R. deFilippi, Rajat Deo, Alan S. Go, Jiang He, Bonnie Ky, James P. Lash, Stephen L. Seliger, Elsayed Z. Soliman, Michael G. Shlipak, Nisha Bansal
Format: Article
Language:English
Published: Wiley 2020-07-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.119.014385
_version_ 1819205513562292224
author Sri Lekha Tummalapalli
Leila R. Zelnick
Amanda H. Andersen
Robert H. Christenson
Christopher R. deFilippi
Rajat Deo
Alan S. Go
Jiang He
Bonnie Ky
James P. Lash
Stephen L. Seliger
Elsayed Z. Soliman
Michael G. Shlipak
Nisha Bansal
author_facet Sri Lekha Tummalapalli
Leila R. Zelnick
Amanda H. Andersen
Robert H. Christenson
Christopher R. deFilippi
Rajat Deo
Alan S. Go
Jiang He
Bonnie Ky
James P. Lash
Stephen L. Seliger
Elsayed Z. Soliman
Michael G. Shlipak
Nisha Bansal
author_sort Sri Lekha Tummalapalli
collection DOAJ
description Background The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a measure of heart failure (HF) health status. Worse KCCQ scores are common in patients with chronic kidney disease (CKD), even without diagnosed heart failure (HF). Elevations in the cardiac biomarkers GDF‐15 (growth differentiation factor‐15), galectin‐3, sST2 (soluble suppression of tumorigenesis‐2), hsTnT (high‐sensitivity troponin T), and NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide) likely reflect subclinical HF in CKD. Whether cardiac biomarkers are associated with low KCCQ scores is not known. Methods and Results We studied participants with CKD without HF in the multicenter prospective CRIC (Chronic Renal Insufficiency Cohort) Study. Outcomes included (1) low KCCQ score <75 at year 1 and (2) incident decline in KCCQ score to <75. We used multivariable logistic regression and Cox regression models to evaluate the associations between baseline cardiac biomarkers and cross‐sectional and longitudinal KCCQ scores. Among 2873 participants, GDF‐15 (adjusted odds ratio 1.42 per SD; 99% CI, 1.19–1.68) and galectin‐3 (1.28; 1.12–1.48) were significantly associated with KCCQ scores <75, whereas sST2, hsTnT, and NT‐proBNP were not significantly associated with KCCQ scores <75 after multivariable adjustment. Of the 2132 participants with KCCQ ≥75 at year 1, GDF‐15 (adjusted hazard ratio, 1.36 per SD; 99% CI, 1.12–1.65), hsTnT (1.20; 1.01–1.44), and NT‐proBNP (1.30; 1.08–1.56) were associated with incident decline in KCCQ to <75 after multivariable adjustment, whereas galectin‐3 and sST2 did not have significant associations with KCCQ decline. Conclusions Among participants with CKD without clinical HF, GDF‐15, galectin‐3, NT‐proBNP, and hsTnT were associated with low KCCQ either at baseline or during follow‐up. Our findings show that elevations in cardiac biomarkers reflect early symptomatic changes in HF health status in CKD patients.
first_indexed 2024-12-23T04:52:54Z
format Article
id doaj.art-8822a7a1769242ceb5a38a0351d2b4e2
institution Directory Open Access Journal
issn 2047-9980
language English
last_indexed 2024-12-23T04:52:54Z
publishDate 2020-07-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj.art-8822a7a1769242ceb5a38a0351d2b4e22022-12-21T17:59:24ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802020-07-0191310.1161/JAHA.119.014385Association of Cardiac Biomarkers With the Kansas City Cardiomyopathy Questionnaire in Patients With Chronic Kidney Disease Without Heart FailureSri Lekha Tummalapalli0Leila R. Zelnick1Amanda H. Andersen2Robert H. Christenson3Christopher R. deFilippi4Rajat Deo5Alan S. Go6Jiang He7Bonnie Ky8James P. Lash9Stephen L. Seliger10Elsayed Z. Soliman11Michael G. Shlipak12Nisha Bansal13Division of Nephrology Department of Medicine University of California San Francisco CAKidney Research Institute University of Washington Seattle WABiostatistics and Epidemiology and Informatics Perelman School of Medicine at the University of Pennsylvania Philadelphia PADepartment of Pathology University of Maryland School of Medicine Baltimore MDUniversity of Maryland School of Medicine Baltimore MDDivision of Cardiovascular Medicine University of Pennsylvania Philadelphia PADepartment of Epidemiology and Biostatistics University of California, San Francisco San Francisco San Francisco CATulane University New Orleans LADivision of Cardiology Department of Medicine Perelman School of Medicine at the University of Pennsylvania Philadelphia PADepartment of Medicine University of Illinois at Chicago ILDivision of Nephrology University of Maryland School of Medicine Baltimore MDDepartment of Epidemiology and Prevention Epidemiological Cardiology Research Center Wake Forest University School of Medicine Winston‐Salem NCKidney Health Research Collaborative University of California San Francisco CAKidney Research Institute University of Washington Seattle WABackground The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a measure of heart failure (HF) health status. Worse KCCQ scores are common in patients with chronic kidney disease (CKD), even without diagnosed heart failure (HF). Elevations in the cardiac biomarkers GDF‐15 (growth differentiation factor‐15), galectin‐3, sST2 (soluble suppression of tumorigenesis‐2), hsTnT (high‐sensitivity troponin T), and NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide) likely reflect subclinical HF in CKD. Whether cardiac biomarkers are associated with low KCCQ scores is not known. Methods and Results We studied participants with CKD without HF in the multicenter prospective CRIC (Chronic Renal Insufficiency Cohort) Study. Outcomes included (1) low KCCQ score <75 at year 1 and (2) incident decline in KCCQ score to <75. We used multivariable logistic regression and Cox regression models to evaluate the associations between baseline cardiac biomarkers and cross‐sectional and longitudinal KCCQ scores. Among 2873 participants, GDF‐15 (adjusted odds ratio 1.42 per SD; 99% CI, 1.19–1.68) and galectin‐3 (1.28; 1.12–1.48) were significantly associated with KCCQ scores <75, whereas sST2, hsTnT, and NT‐proBNP were not significantly associated with KCCQ scores <75 after multivariable adjustment. Of the 2132 participants with KCCQ ≥75 at year 1, GDF‐15 (adjusted hazard ratio, 1.36 per SD; 99% CI, 1.12–1.65), hsTnT (1.20; 1.01–1.44), and NT‐proBNP (1.30; 1.08–1.56) were associated with incident decline in KCCQ to <75 after multivariable adjustment, whereas galectin‐3 and sST2 did not have significant associations with KCCQ decline. Conclusions Among participants with CKD without clinical HF, GDF‐15, galectin‐3, NT‐proBNP, and hsTnT were associated with low KCCQ either at baseline or during follow‐up. Our findings show that elevations in cardiac biomarkers reflect early symptomatic changes in HF health status in CKD patients.https://www.ahajournals.org/doi/10.1161/JAHA.119.014385cardiac biomarkersheart failurequality of life
spellingShingle Sri Lekha Tummalapalli
Leila R. Zelnick
Amanda H. Andersen
Robert H. Christenson
Christopher R. deFilippi
Rajat Deo
Alan S. Go
Jiang He
Bonnie Ky
James P. Lash
Stephen L. Seliger
Elsayed Z. Soliman
Michael G. Shlipak
Nisha Bansal
Association of Cardiac Biomarkers With the Kansas City Cardiomyopathy Questionnaire in Patients With Chronic Kidney Disease Without Heart Failure
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
cardiac biomarkers
heart failure
quality of life
title Association of Cardiac Biomarkers With the Kansas City Cardiomyopathy Questionnaire in Patients With Chronic Kidney Disease Without Heart Failure
title_full Association of Cardiac Biomarkers With the Kansas City Cardiomyopathy Questionnaire in Patients With Chronic Kidney Disease Without Heart Failure
title_fullStr Association of Cardiac Biomarkers With the Kansas City Cardiomyopathy Questionnaire in Patients With Chronic Kidney Disease Without Heart Failure
title_full_unstemmed Association of Cardiac Biomarkers With the Kansas City Cardiomyopathy Questionnaire in Patients With Chronic Kidney Disease Without Heart Failure
title_short Association of Cardiac Biomarkers With the Kansas City Cardiomyopathy Questionnaire in Patients With Chronic Kidney Disease Without Heart Failure
title_sort association of cardiac biomarkers with the kansas city cardiomyopathy questionnaire in patients with chronic kidney disease without heart failure
topic cardiac biomarkers
heart failure
quality of life
url https://www.ahajournals.org/doi/10.1161/JAHA.119.014385
work_keys_str_mv AT srilekhatummalapalli associationofcardiacbiomarkerswiththekansascitycardiomyopathyquestionnaireinpatientswithchronickidneydiseasewithoutheartfailure
AT leilarzelnick associationofcardiacbiomarkerswiththekansascitycardiomyopathyquestionnaireinpatientswithchronickidneydiseasewithoutheartfailure
AT amandahandersen associationofcardiacbiomarkerswiththekansascitycardiomyopathyquestionnaireinpatientswithchronickidneydiseasewithoutheartfailure
AT roberthchristenson associationofcardiacbiomarkerswiththekansascitycardiomyopathyquestionnaireinpatientswithchronickidneydiseasewithoutheartfailure
AT christopherrdefilippi associationofcardiacbiomarkerswiththekansascitycardiomyopathyquestionnaireinpatientswithchronickidneydiseasewithoutheartfailure
AT rajatdeo associationofcardiacbiomarkerswiththekansascitycardiomyopathyquestionnaireinpatientswithchronickidneydiseasewithoutheartfailure
AT alansgo associationofcardiacbiomarkerswiththekansascitycardiomyopathyquestionnaireinpatientswithchronickidneydiseasewithoutheartfailure
AT jianghe associationofcardiacbiomarkerswiththekansascitycardiomyopathyquestionnaireinpatientswithchronickidneydiseasewithoutheartfailure
AT bonnieky associationofcardiacbiomarkerswiththekansascitycardiomyopathyquestionnaireinpatientswithchronickidneydiseasewithoutheartfailure
AT jamesplash associationofcardiacbiomarkerswiththekansascitycardiomyopathyquestionnaireinpatientswithchronickidneydiseasewithoutheartfailure
AT stephenlseliger associationofcardiacbiomarkerswiththekansascitycardiomyopathyquestionnaireinpatientswithchronickidneydiseasewithoutheartfailure
AT elsayedzsoliman associationofcardiacbiomarkerswiththekansascitycardiomyopathyquestionnaireinpatientswithchronickidneydiseasewithoutheartfailure
AT michaelgshlipak associationofcardiacbiomarkerswiththekansascitycardiomyopathyquestionnaireinpatientswithchronickidneydiseasewithoutheartfailure
AT nishabansal associationofcardiacbiomarkerswiththekansascitycardiomyopathyquestionnaireinpatientswithchronickidneydiseasewithoutheartfailure